Uncategorized Archives - Page 4 of 232

ThursdayJun 06, 2024 9:00 am

Alternative Products Expo to Showcase Tradeshow At Houston

Cultivators, manufacturers, entrepreneurs, traders, and enthusiasts, are invited to attend the Alternative Products Expo being held June 20-22, 2024, at the George R. Brown Center, in Houston. With its dynamic vibe of food, culture, art, and pulsating nightlife, Houston is the perfect venue for the Alternative Products Expo. The Altpro Expo in Houston is hosted by USA CBD Expo, America’s leading CBD and Hemp Expo event organizers. Over recent years, they have expanded to include the full alternative products range ecosystem. Organized by ZJ Events, the Expo caters to the industry’s best CBD traders, manufacturers, and enthusiasts offering an exciting learning experience under a common arena. With the Houston smoke…

ThursdayJun 06, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Patent Portfolio to 43 Granted Patents Worldwide

Lexaria recently received two new patents granted in the U.S. in its patent families #21 and #24 The new patents complement the company’s efforts in investigating the capabilities of DehydraTECH-CBD to lower blood pressure in humans with hypertension and mitigate epileptic seizures in rodents The company relies on R&D to provide data that enables it to apply for patent protection, supports further investigations and discoveries, as well as increases its chances of potentially receiving FDA approvals According to CEO Chris Bunka, the company’s growing patent portfolio forms the foundation upon which the company forges commercial relationships Lexaria Bioscience (NASDAQ: LEXX),…

MondayJun 03, 2024 9:00 am

Software Effective Solutions Corp. (SFWJ) Joins Others in Applauding Decision to Reschedule Cannabis

Company calls rescheduling a “monumental decision” that signifies a significant shift in U.S. drug policy MedCana CEO notes rescheduling “opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding” SFWJ remains committed to advancing the dialogue around cannabis policy and supporting initiatives that promote responsible access and use Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) has noted a “historic milestone” as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (https://cnw.fm/yNude). The company released an announcement from CEO Jose Gabriel Diaz and…

FridayMay 31, 2024 9:00 am

Golden Triangle Ventures Inc. (GTVH), Subsidiary Focused on Becoming Leaders in Sector Projected to See Billion-Dollar Growth

Recent report notes that the U.S. conferences, concert and event market is on a trajectory of remarkable growth A driving force behind the rapid growth is an increasing demand for unique, immersive experiences Lavish Entertainment is building a reputation for producing high-quality, professional events that offer memorable experiences With a recent analyst report projecting significant growth in the U.S. conferences, concert and event market, Golden Triangle Ventures (OTC: GTVH) and its entertainment division, Lavish Entertainment, are strengthening their strategic position in the space at an ideal time. “The United States conferences, concert and event market is on a trajectory of remarkable growth,…

WednesdayMay 29, 2024 12:00 pm

Software Effective Solutions Corp. (SFWJ) Subsidiary Expands Global Footprint, Becomes Leading Infrastructure Supplier for Colombia’s Top Flower Producers

MedCana subsidiary is expanding reach both domestically and internationally Company is strengthening support, sales operations through international partnerships Eko2o is at the forefront of providing innovative agricultural technology and infrastructure solutions Eko2o S.A.S., a subsidiary of Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), is experiencing significant growth and success, as evidenced by recent news that it has become a key infrastructure supplier for some of Colombia’s largest flower producers (https://cnw.fm/PI8yO). In addition, Eko2o is strengthening its support and sales operations through international partnerships and collaborations, including with Danziger International. “Our solutions stand out in the market, and we are delighted…

WednesdayMay 29, 2024 11:15 am

Golden Triangle Ventures Inc. (GTVH) Subsidiary Shares New Business Model Based on Key Pillars to Ensure Success

Strategic four-pillar business model provides essential piece of Lavish Entertainment’s mission to create an industry-leading entertainment business New model “represents a bold step forward in our journey to develop Lavish Entertainment into a staple in the entertainment industry,” states CEO The company plans to develop, acquire operations in each of plan’s four areas At the core of Golden Triangle Ventures’ (OTC: GTVH) purpose of pursuing ventures in the health, entertainment and technology sectors lies its focus on vertical integration to cut costs and maximize margins. One of the company’s newest ventures — Lavish Entertainment, its entertainment division — embodies this…

TuesdayMay 28, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study; Maintains Study Pace and Rollout for 2024

Lexaria, a global innovator in drug delivery platforms, just concluded its first dosing for its glucagon-peptide-1 (“GLP-1”) human pilot study #2, GLP-1-H24-2 GLP-1, a class of drugs, has demonstrated the ability to address diabetes and weight loss, albeit with poor oral bioavailability, usually as little as 0.8% Lexaria, through its study, looks to demonstrate the effectiveness of its DehydraTECH(TM) technology in improving GLP-1’s bioavailability, opening up a vast worldwide market Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just concluded its first dosing for its glucagon-peptide-1 (“GLP-1”) human pilot study #2, GLP-1-H24-2 (https://cnw.fm/g0mZl). This follows the recent…

WednesdayMay 15, 2024 10:30 am

Software Effective Solutions Corp. (SFWJ) Subsidiary Looks to Ride Expansion Trend, Moving into Central American Cannabis Markets

The global textile industry is increasingly turning to hemp, celebrating the plant’s ability to enhance soil health, support biodiversity, suppress weeds, and increase yields Central American expansion is part of MedCana’s broader strategy to strengthen its presence in the global cannabis and agricultural technology sectors MedCana is a pioneer in the integration of technology and agriculture, focusing on cannabis and emerging technologies Worldwide, more farmers are opting to grow hemp because of its agricultural benefits. Leveraging that trend, Eko2o Environmental Solutions S.A.S., a majority-owned subsidiary of Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), is expanding operations into Costa Rica and the…

TuesdayMay 14, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners with the National Research Council of Canada for DehydraTECH-GLP-1 Mode of Action Investigation

Lexaria, a global innovator in drug delivery platforms, just announced its newest relationship with the National Research Council of Canada (“NRC”) Specific molecular characteristics of the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, processed with Lexaria’s patented DehydraTECH(TM) technology, will be evaluated Previous research has shown that using a DehydraTECH-semaglutide capsule composition yields a 43% higher peak level of semaglutide in blood compared to Rybelsus(R). This has potential for increased weight-loss and diabetic control Lexaria’s management is confident that this partnership will complement the company’s animal and human pharmacokinetic and pharmacodynamic studies for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a…

ThursdayMay 09, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Set to Extend Operational Runway to 2025 Following Warrant Exercise and Issuance

Lexaria has entered an agreement wherein an existing accredited investor has exercised all their warrants to purchase shares The company has received $4.7 million from this undertaking, prior to deducting estimated offering expenses Proceeds fully fund Lexaria’s entire planned 2024 GLP-1 R&D program, leaving additional excess capital for general purposes Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its entry into a warrant exercise agreement with an existing accredited investor to exercise in full certain existing warrants initially issued in October 2023 and February 2024. The warrants will be exercised at $0.97 and $2.185 per…

News and publishing service for CBD related companies

Contact us: 512.354.7000

Category: Uncategorized